169 related articles for article (PubMed ID: 32837030)
1. Novel Stem Cells and Nucleic Acid-Based Vaccine Trials Against Viral Outbreak: A Systematic Evaluation During COVID-2019 Pandemic.
Maurya CK; Misra R; Sharma P; Singh N; Awasthi H; Agrawal R; Misra S; Dwivedi S
Indian J Clin Biochem; 2020 Oct; 35(4):397-409. PubMed ID: 32837030
[TBL] [Abstract][Full Text] [Related]
2. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
3. A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic.
Sumon TA; Hussain MA; Hasan MT; Hasan M; Jang WJ; Bhuiya EH; Chowdhury AAM; Sharifuzzaman SM; Brown CL; Kwon HJ; Lee EW
Front Mol Biosci; 2020; 7():585899. PubMed ID: 33569389
[TBL] [Abstract][Full Text] [Related]
4. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
Gudadappanavar AM; Benni J
J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
[TBL] [Abstract][Full Text] [Related]
5. A review on Promising vaccine development progress for COVID-19 disease.
Belete TM
Vacunas; 2020; 21(2):121-128. PubMed ID: 32837460
[TBL] [Abstract][Full Text] [Related]
6. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
7. COVID-19: Coronavirus Vaccine Development Updates.
Zhao J; Zhao S; Ou J; Zhang J; Lan W; Guan W; Wu X; Yan Y; Zhao W; Wu J; Chodosh J; Zhang Q
Front Immunol; 2020; 11():602256. PubMed ID: 33424848
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccines: concerns beyond protective efficacy and safety.
Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
[TBL] [Abstract][Full Text] [Related]
9. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
10. The 2020 race towards SARS-CoV-2 specific vaccines.
Karpiński TM; Ożarowski M; Seremak-Mrozikiewicz A; Wolski H; Wlodkowic D
Theranostics; 2021; 11(4):1690-1702. PubMed ID: 33408775
[TBL] [Abstract][Full Text] [Related]
11. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
12. Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives.
Kotta S; Aldawsari HM; Badr-Eldin SM; Alhakamy NA; Md S; Nair AB; Deb PK
Front Mol Biosci; 2020; 7():606393. PubMed ID: 33282914
[TBL] [Abstract][Full Text] [Related]
13. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
Front Immunol; 2020; 11():1880. PubMed ID: 32973779
[TBL] [Abstract][Full Text] [Related]
14. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies.
Zumla A; Wang FS; Ippolito G; Petrosillo N; Agrati C; Azhar EI; Chang C; El-Kafrawy SA; Osman M; Zitvogel L; Galle PR; Locatelli F; Gorman E; Cordon-Cardo C; O'Kane C; McAuley D; Maeurer M
Int J Infect Dis; 2020 Jul; 96():431-439. PubMed ID: 32425638
[TBL] [Abstract][Full Text] [Related]
15. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19.
Sharma O; Sultan AA; Ding H; Triggle CR
Front Immunol; 2020; 11():585354. PubMed ID: 33163000
[TBL] [Abstract][Full Text] [Related]
16. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
17. Perspectives on RNA Vaccine Candidates for COVID-19.
Borah P; Deb PK; Al-Shar'i NA; Dahabiyeh LA; Venugopala KN; Singh V; Shinu P; Hussain S; Deka S; Chandrasekaran B; Jaradat DMM
Front Mol Biosci; 2021; 8():635245. PubMed ID: 33869282
[TBL] [Abstract][Full Text] [Related]
18. Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19.
Bezbaruah R; Borah P; Kakoti BB; Al-Shar'I NA; Chandrasekaran B; Jaradat DMM; Al-Zeer MA; Abu-Romman S
Front Mol Biosci; 2021; 8():635337. PubMed ID: 33937326
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccine candidates and vaccine development platforms available worldwide.
Duman N; ALzaidi Z; Aynekin B; Taskin D; Demirors B; Yildirim A; Sahin IO; Bilgili F; Turanli ET; Beccari T; Bertelli M; Dundar M
J Pharm Anal; 2021 Dec; 11(6):675-682. PubMed ID: 34540318
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 vaccine candidates in rapid development.
Li L; Guo P; Zhang X; Yu Z; Zhang W; Sun H
Hum Vaccin Immunother; 2021 Mar; 17(3):644-653. PubMed ID: 33121319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
